|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2025―Apr―12 |
The trend of the HIV infection epidemic during the COVID-19 pandemic in the Republic of Тajikistan |
R. A. Tursunzoda |
2 |
[GO] |
2025―Feb―17 |
Duration of SARS-CоV-2 virus shedding in COVID-19 patients with HIV infection |
D. A. Lioznov, O. E. Pobegalova, N. V. Sabadash, E. Yu. Karnaukhova, T. V. Antonova, A. B. Komissarov, A. A. Ivanova |
3 |
[GO] |
2025―Feb―17 |
Characteristics of the COVID-19 epidemic process in the Volga Federal District in 2020-2023 |
I. N. Tuzova, S. A. Sarskov, E. E. Kuzovatova, A. V. Polyanina, N. N. Zaitseva |
4 |
[GO] |
2025―Feb―17 |
Immune dysregulation in long covid may contribute to the development of neurological disorders through the effects of cytokines |
V. V. Rassokhin, N. A. Arsentieva, Z. R. Korobova, N. E. Lyubimova, O. K. Batsunov, E. V. Boeva, et al. (+4) A. A. Knizhnikova, A. O. Norka, N. B. Khalezova, N. A. Belyakov |
5 |
[GO] |
2024―Nov―29 |
Neuromuscular and neuropsychiatric disorders in humans due to preventive vaccination against COVID-19 infection |
I. M. Ulyukin, V. V. Rassokhin, A. A. Sechin, E. S. Orlova |
6 |
[GO] |
2024―Nov―29 |
Analysis of fatal cases of pneumocystis pneumonia in HIV-infected patients with COVID-19 |
A. V. Kireeva, A. E. Safonova, E. Yu. Karnaukhova, E. V. Karnaukhov, D. A. Lioznov |
7 |
[GO] |
2024―Sep―09 |
Optimal choice of indicators for timely assessment of the prognosis of COVID-19 in hospitalized patients |
T. A. Ruzhentsova, D. B. Mirzajonova, Zh. Zh. Zhanibekov, D. A. Khavkina, P. V. Chukhliaev, O. Yu. Borisova, N. A. Meshkova |
8 |
[GO] |
2024―Sep―09 |
Features of the clinical course of the new coronavirus infection in HIV-infected patients |
O. V. Azovtseva, T. N. Tkachenko, E. A. Kurbatova |
9 |
[GO] |
2024―Jan―22 |
Delayed mental, neurological and somatic disorders associated with COVID-19 |
N. A. Belyakov, V. V. Rassokhin, N. A. Totolyan, E. V. Boeva, A. S. Bobreshova, N. B. Khalezova, et al. (+2) Ya. B. Kushnir, A. O. Norka |
10 |
[GO] |
2024―Jan―22 |
Attitude to vaccination against COVID-19 in patients with non-psychotic mental disorders |
N. B. Khalezova, Z. E. Kostyleva, M. Ya. Kissin, E. V. Boeva |
11 |
[GO] |
2023―Okt―25 |
Medicak techniligies assesment in COVID-19 |
A. S. Kolbin, Yu. M. Gomon |
12 |
[GO] |
2023―Jul―21 |
Mortality from tuberculosis and HIV infection in Russia in the period before and during the COVID-19 pandemic |
E. B. Tsybikova, I. S. Lapshina |
13 |
[GO] |
2023―Mai―03 |
The use of janus kinase inhibitors anti-interleukin therapy in the Russian Federation with COVID-19: pharmacoepidemiological study |
Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, A. S. Kolbin, A. A. Kalyapin, A. M. Fakhrutdinova, T. A. Usmanova |
14 |
[GO] |
2023―Mai―03 |
Mechanisms of central nervous system damage in COVID-19 |
V. V. Rassokhin, E. I. Svetashova, A. A. Shcherbakov, A. Yu. Polushin, M. A. Kucher, I. V. Kazantsev, et al. (+7) O. V. Goloshchapov, R. V. Klementieva, A. A. Sinyaev, V. N. Ovechkina, A. A. Lazarev, M. O. Popova, A. D. Kulagin |
15 |
[GO] |
2023―Jan―26 |
Time-related changes in the titer of virus neutralizing antibodies against SARS-CoV-2 after COVID-19 in patients with HIV infection |
O. E. Pobegalova, N. V. Kozmovskaya, N. E. Monakhov, A. N. Kholodnaya, D. M. Danilenko, T. V. Antonova, A. D. Lioznov |
16 |
[GO] |
2023―Jan―26 |
COVID-19 in patients with HIV: case-series |
V. H. Fazylov, A. F. Oleynik, Ch. G. Revathy, Ah. M. Fayyadh, O. F. Abdullah |
17 |
[GO] |
2023―Jan―26 |
Tuberculosis combined with HIV infection in Russia in the period before - and during the COVID-19 pandemic |
E. B. Tsybikova |
18 |
[GO] |
2023―Jan―26 |
Combination of new coronavirus infection and HIV infection |
E. A. Belashov, A. N. Isakov, V. A. Zinserling |
19 |
[GO] |
2022―Nov―11 |
Determining factors of a personalized approach to patients with HIV during the COVID-19 pandemic |
S. L. Serebryakova, E. V. Boeva, M. A. Moisa, S. I. Dyrul, S. V. Ogurtsova, O. N. Leonov, A. Yu. Kovelenov |
20 |
[GO] |
2022―Aug―31 |
COVID-19 i in the setting of acute lymphoblastic leukaemia (case analysis, resulting in death) |
D. О. Ivanov, Y. V. Petrenko, V. А. Reznik, V. N. Timchenko, Е. B. Pavlova, Т. М. Chernova, et al. (+7) С. L. Bannova, G. V. Kondratyev, О. L. Krasnogorskaya, М. А. Shakmayeva, М. B. Paneyah, Е. P. Fedotova, R. А. Nasyrov |
21 |
[GO] |
2022―Mai―19 |
Course of COVID-19 in patients with HIV infection and morphological changes in the lungs with a combined damage SARS-CoV2 and secondary infections |
D. V. Kapustin, E. I. Krasnova, N. I. Khokhlova, O. M. Shishkova, Ya. S. Ulyanova, A. I. Tyryshkin |
22 |
[GO] |
2022―Mai―19 |
Study of the emotional state of residents of St. Petersburg and the Leningrad region in connection with the forced self-isolation during the COVID-19 pandemic |
E. V. Sitkina, E. S. Smirnova, E. R. Isaeva |
23 |
[GO] |
2022―Mai―19 |
COVID-19 pandemic and its impact on other infections in Northwest Russia |
N. A. Belyakov, E. V. Boeva, O. E. Simakina, Yu. S. Svetlichnaya, S. V. Ogurtsova, S. L. Serebryakova, et al. (+5) E. V. Esaulenko, Z. M. Zagdyn, A. V. Yazenok, D. A. Lioznov, I. O. Stoma |
24 |
[GO] |
2022―Jan―29 |
The frequency of class G immunoglobulins` formation to the SARS-CoV-2 coronavirus in immunization of HIV-infected patients with Gam-COVID-Vac vaccine and the reactogenicity of the vaccine |
V. I. Sergevnin, M. V. Rozhkova, K. V. Ovchinnicov, E. V. Sarmometov |
25 |
[GO] |
2022―Jan―29 |
Postcovid syndrome - polymorphism of disorders in a new coronavirus infection |
N. A. Belyakov, T. N. Trofimova, V. V. Rassokhin, M. G. Rybakova, B. B. Vasiliev |
26 |
[GO] |
2021―Okt―25 |
Social and psychological problems of population vaccination against COVID-19 |
N. A. Belyakov, N. B. Khalezova, E. V. Boyeva, V. V. Rassokhin, O. Ye. Simakina, N. G. Neznanov |
27 |
[GO] |
2021―Okt―25 |
The herd immunity to SARS-CoV-2 among the population of the Nizhny Novgorod region amid the COVID-19 epidemic |
A. Yu. Popova, E. B. Ezhlova, A. A. Melnikova, V. S. Smirnov, L. V. Lyalina, E. I. Efimov, et al. (+8) N. S. Kucherenko, N. N. Zaitseva, N. A. Sadykova, S. A. Sarskov, G. A. Chekhova, T. V. Arbuzova, V. V. Vetrov, A. A. Totolian |
28 |
[GO] |
2021―Okt―25 |
Rehabilitation of patients with COVID-19: the view of an infectious disease specialist and a pulmonologist |
I. O. Stoma, D. Yu. Ruzanov |
29 |
[GO] |
2021―Jun―21 |
The experience of a medical psychologist in a center for treatment of patients with new coronavirus infection (COVID-19) |
R. Yu. Shindrikov, V. E. Khilov, E. R. Isaeva, V. M. Teplov, E. A. Karpova, E. A. Tsebrovskaya |
30 |
[GO] |
2021―Jun―21 |
X-RAY-morphological features of the current COVID-19 and HIV infection |
A. A. Gaus, N. V. Klimova |
31 |
[GO] |
2021―Jun―21 |
The dynamics of the COVID-19 pandemic and formation of the postcovid period in Russia |
N. A. Belyakov, T. N. Trofimova, O. E. Simakina, V. V. Rassokhin, S. L. Serebryakova |
32 |
[GO] |
2021―Apr―27 |
New coronoviral infection (COVID-19) combined with tuberculosis in patients at late stages of HIV infection with immunodeficiency |
A. V. Mishina, V. Yu. Mishin, A. E. Ergeshov, A. L. Sobkin, N. V. Sergeeva, S. V. Pilipenko, V. V. Romanov |
33 |
[GO] |
2021―Apr―27 |
Humoral immunity to SARS-CoV-2 among the population of Murmansk region amid COVID-19 epidemic |
A. Yu. Popova, E. B. Ezhlova, A. A. Melnikova, L. A. Lukicheva, N. I. Nikitina, L. V. Lyalina, et al. (+14) V. S. Smirnov, N. S. Koltsov, M. V. Ermakova, A. K. Kubashev, V. V. Kuznetsova, T. V. Denisova, N. V. Gurina, I. V. Ziborov, I. V. Gryazova, N. A. Pankova, P. I. Konoshkin, N. I. Mikheeva, A. A. Sharova, A. A. Totolian |
34 |
[GO] |
2021―Feb―09 |
Immunopathogenesis and perspectives for immunotherapy of coronavirus infection |
A. S. Simbirtsev |
35 |
[GO] |
2020―Aug―13 |
Epidemiology, clinical picture, diagnostics, assessment of the severity of the disease COVID-19 |
V. V. Rassokhin, A. V. Samarina, N. A. Belyakov, T. N. Trofimova, O. V. Lukina, P. V. Gavrilov, O. A. Grinenko |
36 |
[GO] |
2020―Aug―13 |
COVID-19 coronavirus infection. Treatment and prevention |
S. F. Bagnenko, V. V. Rassokhin, N. A. Belyakov, E. V. Boeva, E. B. Yastrebova |
37 |
[GO] |
2020―Mai―27 |
CORONAVIRUS INFECTIOUS DISEASE COVID-19. NATURE OF VIRUS, PATHOGENESIS, CLINICAL MANIFESTATIONS, REPORT 1 |
N. A. Belyakov, V. V. Rassokhin, E. B. Yastrebova |